Diabetes

The brain may be a new drug target for longer term control of diabetes. Two new studies on rodents have investigated how a certain peptide works to induce remission for animals with diabetes, which could lead to new breakthroughs in human treatments.

Scientists at the Joslin Diabetes Center have developed a new gene-editing technique that converts a subject's own white fat cells into brown fat cells, which could then be transplanted as a way of treating obesity and diabetes.

A new synthetic film developed at MIT could become a powerful tool in helping manage diabetes, with the ability to self-assemble in the intestine to block the absorption of glucose and safely dissolve thereafter. And its potential mightn’t end there.

A team from UC San Francisco has demonstrated the potential in using a smartphone camera to diagnose type 2 diabetes. The technique needs no additional hardware other than a smartphone camera, and is over 80 percent accurate in detecting diabetes.

Scientists have shown how to activate energy-burning brown fat in mice, which helps shed weight and improves health. Results have been hard to replicate in humans, but a new study has found that we might be targeting the wrong receptor in our bodies.

Researchers have for the first time studied the gut microbiome of subjects with prediabetes, revealing a person’s unique gut bacteria population could be used to predict their likelihood of developing type 2 diabetes.

Researchers have developed an ultrafast-acting form of insulin that promises to work up to four times faster than current formulations. The novel drug has only been tested in animals so far but the researchers hope to test it in human trials soon.

New results from a clinical trial evaluating the efficacy of diet and exercise as a front-line type 2 diabetes treatment reveal nearly two-thirds of patients achieved complete disease remission after just 12 months of lifestyle interventions.

Scientists at the University of Utah have borrowed useful elements of cone snail venom to produce a potent hybrid “mini-insulin” that acts far more swiftly, and could make treating diabetes far more effective as a result.

Imagine a device that lets people with diabetes use an app to give themselves a boost of insulin when they need it, without an injection. A prototype device can do just that, using electricity to control gene expression in encapsulated beta cells.

An international team of scientists has developed technology that could detect diabetes-induced blindness in its early stages, using a smartphone as the basis for a low-cost diagnostic method that could greatly improve care in developing regions.

A new experimental drug could help mitigate some of the dangerous side effects caused by a once-promising diabetes medication. Animal tests suggest the combination treatment is both safe and effective at helping regulate blood sugar levels in diabetics.